InsurTech Partnership Strategy — Build vs. Buy vs. Partner for AI Capabilities
06.10.2026
State of Play: The Capital Market Is Already Voting
The InsurTech investment market has made its position clear, and it is not neutral. Global InsurTech investment reached $943.4 million across 42 deals in Q1 2026, a 27% year-on-year increase, with approximately 75% of new capital flowing to companies with AI at the core of their product proposition — a share that has roughly doubled since 2023 (Gallagher Re via InsuraBeat, May 2026).
The valuation gap is structural, not cyclical. The average deal size for AI-focused InsurTech rounds in Q1 2026 was $33.7 million, compared to $14.2 million for non-AI rounds — a ratio above 2:1 that has been widening since mid-2025. Non-AI InsurTech companies are not just raising less capital. They are being re-rated to legacy multiples by investors who require demonstrated improvement in combined ratio, claims cycle time, or customer acquisition cost before committing capital.
For established carriers evaluating how to acquire AI capabilities, the external market is not waiting for internal deliberation. The question is not whether to act. It is which path produces the right capability at the right speed without creating integration debt that compounds for the next decade.
Why the Path Decision Matters More Than the Capability Decision
Most carriers frame the build vs. buy vs. partner question as a technology choice. It is not. It is a speed-to-production question, a talent question, and a data-ownership question — each of which carries a different risk profile depending on where the carrier sits on the AI maturity curve.
The majority of carriers are still catching up. KMS Technology's 2026 State of AI for Insurance Carriers report — drawing on KPMG's AI Value Model — documents a clear three-tier structure: a front-runner group deploying AI in production across multiple business units simultaneously; a middle group with fragmented individual use cases that do not compound; and an early-stage group whose data and technical infrastructure is not yet ready to support meaningful AI deployment (KMS Technology, 2026). The path decision that is correct for Tier 1 is frequently wrong for Tier 2.
Getting the path wrong does not produce a neutral outcome. It produces either a multi-year internal build program that delivers a capability the market has already commoditized, a vendor deployment that cannot be customized to the carrier's specific risk logic, or a partnership that creates a dependency on a third party's roadmap for a function that is core to the carrier's competitive differentiation.
The Build Path: When Internal Development Is the Right Choice
The Build option is the right choice when the capability being built is genuinely differentiating and the carrier possesses the data, talent, and governance infrastructure to execute it. Neither condition is common. KMS Technology identifies data infrastructure as the most underinvested layer in almost every carrier's AI foundation and business-side AI literacy as the weakest capability across operational functions — two prerequisites that internal build programs require before the first model ships.
The Fit: Proprietary risk scoring models built on data the carrier owns and competitors cannot access. Highly customized actuarial algorithms for specialty lines where no commercial vendor covers the relevant logic. Internal AI assistants trained on proprietary claims and underwriting knowledge that would create competitive exposure if hosted on a third-party platform.
The Risk: Build timelines in insurance average 18-36 months for production deployment. Market-tested vendor equivalents ship in weeks. The carrying cost of a 24-month internal build program — during which competitors deploy vendor and partner solutions — is not recoverable.
Key Takeaway: Build when the capability is differentiated, the data is proprietary, and the talent is already in house. When any one of those three conditions is absent, build programs fail to deliver what their business cases projected.
The Buy Path: When Vendor Procurement Is Faster and Safer
The Buy option — procuring a commercial platform or point solution — is the right choice when the capability being acquired is well-defined, vendor solutions have achieved production maturity, and integration complexity does not exceed the carrier's technical capacity. Claims triage automation, document processing, and fraud scoring all meet this definition. The vendor has already absorbed the development and iteration cost. The carrier acquires production-ready capability at a fraction of the build cost.
The Fit: Commodity AI functions — submission automation, FNOL intake, reserve adequacy scoring — where the differentiation comes from the quality of the carrier's data, not the proprietary nature of the model. Core platform modernization, where an established vendor (Guidewire, Duck Creek, Majesco) provides the infrastructure and the carrier configures on top. Carriers whose internal talent cannot support a build program without multi-year hiring.
The Risk: Vendor solutions are configured to the majority use case. Carriers with unusual product logic, specialty line complexity, or state-specific regulatory requirements frequently discover that vendor configuration boundaries are reached faster than implementation estimates projected. Post 7 of this series documented the scope explosion dynamic directly: carriers whose embedded logic exceeds a platform's native configuration scope end up funding custom development at platform licensing prices, with SI engagement timelines — precisely the outcome the Buy decision was supposed to avoid.
The Partner Path: When InsurTech Collaboration Delivers What Neither Can Alone
The Partner option — a commercial or strategic relationship with an InsurTech provider — occupies the space between Build and Buy, and it is where the most active market innovation is happening in 2026. Rather than building from scratch or deploying a generic platform, carriers access specialized AI capabilities developed by InsurTech companies with deep domain focus, while retaining the carrier's distribution infrastructure, regulatory licenses, and policyholder relationships that InsurTechs cannot replicate.
The Fit: Carriers who need speed-to-production in a specific capability area and are willing to co-develop with a vendor whose roadmap aligns with their strategic priorities. The named partnership activity in 2026 illustrates the model. James River Insurance and Kalepa partnered specifically to advance AI-driven underwriting efficiency in the E&S market — a specialty context where a generic underwriting platform would not cover the required logic. Starr Insurance selected Five Sigma and its multi-agent AI Claims Expert (Clive) specifically for specialty claims operations where standard claims platforms leave gaps. Quantexa launched a claims AI accelerator directly on Guidewire ClaimCenter, giving carriers real-time fraud detection and contextual analytics inside the platform they already run (FinTech Global, February 2026).
The Risk: Partnership dependency. When a function that is core to the carrier's competitive model runs on a third party's platform, the carrier's roadmap becomes partially contingent on the partner's funding status, acquisition trajectory, and product priorities. The $33.7 million average AI InsurTech round in Q1 2026 signals institutional capital behind leading platforms — but the 2021-2023 correction produced a cohort of well-funded InsurTechs that subsequently ran out of runway, taking carrier integrations with them.
Key Takeaway: Partnership is the fastest path to production for well-defined, domain-specific AI capabilities — but only when the partner's financial stability, governance architecture, and regulatory compliance posture meet the carrier's partnership desk requirements.
A Five-Question Decision Framework
Before committing to any path, answer these five questions. The answers will surface the correct decision for a specific capability in a specific carrier context. They will also surface the preconditions that must exist before any path can succeed.
1. Is this capability differentiating or commodity? If competitors who build or buy the same capability would close the competitive gap entirely, the case for Build on proprietary foundations weakens. If the differentiation comes from how the carrier uses the output — not the model itself — Buy or Partner is faster and cheaper.
2. Does the carrier own data that a vendor or partner cannot access? Proprietary data is the only durable moat in AI. If the answer is yes and the data is AI-ready, the Build case strengthens. If the data is fragmented, ungoverned, or inaccessible (as it is for 80% of carriers, per Post 5 of this series), no path produces a reliable model until the data layer is resolved first.
3. Can the internal team produce a production deployment in 12 months? If the honest answer is no — due to talent gaps, competing priorities, or governance delays — the Build path will produce a pilot that never reaches production. The carrier will have spent 18 months building what a partner could have delivered in 90 days.
4. Does any vendor solution cover the specific logic this use case requires? Specialty and E&S lines, complex commercial products, and carriers with deep actuarial customization frequently find that vendor configuration models reach their boundaries at exactly the point where the carrier's differentiated logic begins. The due diligence question is not whether the vendor platform handles the majority use case. It is whether it handles this carrier's use case without custom development.
5. Can the carrier absorb partner dependency for this function over a 3-5 year horizon? If the answer is no — because the function is too central to the operating model — the partner path creates strategic risk that the initial speed-to-production advantage does not offset.
The New Governance Filter Carrier Partnership Desks Now Apply
The evaluation criteria for InsurTech partnerships shifted structurally in 2026. Governance compliance architecture is now a deal filter, not a due diligence checkbox. Carrier partnership teams in jurisdictions covered by APRA, MAS, IRDAI, and US state AI guidelines are requiring InsurTech vendors to demonstrate explainability frameworks, audit trails, and regulatory compliance architecture before commercial agreements proceed — regardless of the technology's capability (InsuraBeat, May 2026).
This is not a compliance burden. It is a quality signal. InsurTech vendors who cannot produce explainability documentation, bias testing evidence, and regulatory clearance architecture are filtering themselves out of carrier partnerships — accurately, because their models would not survive the regulatory audits that carriers are required to pass. The carriers generating the best partnership outcomes are those who applied governance requirements as a partner selection criterion before committing to an integration, not after.
Closing the Series: From Pilot to Production
Nine posts in this series have traced the same structural finding from every angle. The carriers closing the gap between AI activity and AI impact share a single operating characteristic: they sequence correctly. Data foundation before model deployment. System comprehension before platform selection. Governance architecture before partnership commitment. Use-case readiness before enterprise-wide rollout.
DOOR3's AI Pathfinder for Insurance applies that same sequencing logic to the Build vs. Buy vs. Partner decision. Phase 1 produces the capability inventory, data readiness assessment, and governance gap analysis that determines which path is appropriate for each use case — before any vendor contract is signed, any internal sprint is scoped, or any partnership term sheet is reviewed. DOOR3's AI consulting work with insurers including AIG and Munich Re consistently surfaces the same finding: the most expensive mistake in insurance AI is committing to a path before the preconditions for that path exist.
The path from the current state to custom insurance software and an AI-native operating model is not a single architecture decision. It is a sequence of correctly ordered steps — each one building the foundation the next requires. Ping An's agentic AI deployment generating $4.2 billion in new insurance sales in a single quarter is not a technology story. It is the compounded result of a decade of correct sequencing in data, infrastructure, and governance — applied at scale.
The carriers that will define the next decade of P&C insurance are not the ones with the most ambitious AI roadmaps. They are the ones who built the foundations those roadmaps require — and then executed with discipline.
Salvatore Magnone is a father, veteran, and a co-founder, a repeat offender in the best way in fact, and a long-time collaborator at DOOR3. Sal builds successful, multinational, technology companies and runs obstacle courses. He teaches business and military strategy at the university level and directly to entrepreneurs and military leaders.
